Corporate Board Profile
Tech Score: 0/100
Filing Date | Source Excerpt |
---|---|
2004-11-26 | Elazar Rabbani, Ph.D., Chairman of the Board of Directors and CEO, annual salary of $430,942 and a bonus of $275,000 for fiscal year ended July 31, 2004. |
2005-11-28 | Elazar Rabbani, Ph.D. is Chairman of the Board of Directors and Chief Executive Officer. He is 61 years old. Compensation includes salary $442,200 and bonus $283,250 for fiscal year 2005. |
2006-11-27 | Dr. Elazar Rabbani (age 62) Enzo Biochem's founder has served as the Company's Chairman of the Board of Directors and Chief Executive Officer since its inception in 1976. In consideration for Dr. Elazar Rabbani's services as Chairman of the Board of Directors and Chief Executive Officer of the Company for the fiscal year ended July 31, 2006, the Company paid Dr. Rabbani an annual salary of $458,315 and a bonus of $237,000. |
2007-11-28 | Elazar Rabbani, Ph.D. is Enzo Biochem's founder and has served as the Company's Chairman of the Board of Directors and Chief Executive Officer since its inception in 1976. Compensation Table shows total compensation of $974,613 for fiscal year 2007. |
2008-11-28 | DR. ELAZAR RABBANI (age 64) is Enzo Biochem's founder and has served as the Company's Chairman of the Board of Directors and Chief Executive Officer since its inception in 1976. ... The Compensation Committee awarded Dr. Rabbani a $375,000 cash bonus, which represented 73% of his base salary at such date. ... Summary Compensation Table ... Elazar Rabbani, Ph.D 2008 Salary $510,817, Bonus $375,000, Stock Awards $76,950, Option Awards $71,856, Total $1,034,623. |
2009-12-23 | Elazar Rabbani is Chairman of the Board, Chief Executive Officer and Secretary. His total compensation for fiscal 2009 was $1,186,705. |
2011-11-28 | ELAZAR RABBANI, Ph.D. is Enzo Biochem's founder and has served as the Company's Chairman of the Board and Chief Executive Officer since its inception in 1976 and Secretary since November 25, 2009. |
2012-11-27 | Elazar Rabbani, Ph.D. is Enzo Biochem's founder and has served as the Company's Chairman of the Board and Chief Executive Officer since its inception in 1976 and Secretary since November 25, 2009. |
2013-11-27 | Elazar Rabbani, Ph.D. is an Enzo Biochem 27s founder and has served as the Company 27s Chairman of the Board and Chief Executive Officer since its inception in 1976 and Secretary since November 25, 2009. |
2014-11-26 | Elazar Rabbani, Ph.D. is an Enzo Biochem founder and has served as the Company’s Chairman of the Board and Chief Executive Officer since its inception in 1976 and Secretary since November 25, 2009. ... The following table sets forth summary information concerning compensation awarded to, paid to or earned by Elazar Rabbani, Ph.D. ... Total compensation $1,130,027. |
2016-11-23 | Elazar Rabbani, Ph.D. is an Enzo Biochem founder and has served as the Company27s Chairman of the Board and Chief Executive Officer since its inception in 1976 and Secretary since November 25, 2009. Dr. Rabbani has authored numerous scientific publications in the field of molecular biology, in particular, nucleic acid labeling and detection. He is also the lead inventor of many of the Company27s pioneering patents covering a wide range of technologies and products. Dr. Rabbani received his Bachelor of Arts degree from New York University in Chemistry and his Ph.D. in Biochemistry from Columbia University. We believe that Dr. Rabbani27s qualifications to serve on our Board are demonstrated by his extensive knowledge of our industry, accomplishments over the last 39 years, including building our Intellectual Property estate and the commercialization of technology which has generated significant revenues for the Company. The Summary Compensation Table shows his total compensation for fiscal 2016 as $1,407,505. |
2017-11-22 | ELAZAR RABBANI, Ph.D. is an Enzo Biochem founder and has served as the Company’s Chairman of the Board and Chief Executive Officer since its inception in 1976 and Secretary since November 25, 2009. Dr. Rabbani has authored numerous scientific publications in the field of molecular biology, in particular, nucleic acid labeling and detection. He is also the lead inventor of many of the Company’s pioneering patents covering a wide range of technologies and products. Dr. Rabbani received his Bachelor of Arts degree from New York University in Chemistry and his Ph.D. in Biochemistry from Columbia University. He is a member of the American Society for Microbiology. We believe that Dr. Rabbani’s qualifications to serve on our Board are demonstrated by his extensive knowledge of our industry, accomplishments over the last 41 years, including building our Intellectual Property estate and the commercialization of technology which has generated significant revenues for the Company. |
2018-11-21 | Elazar Rabbani, Ph.D. is an Enzo Biochem founder and has served as the Company’s Chairman of the Board and Chief Executive Officer since its inception in 1976 and Secretary since November 25, 2009. |
2020-11-27 | Elazar Rabbani, Ph.D., is an Enzo Biochem founder and has served as the Company’s Chairman of the Board and Chief Executive Officer since its inception in 1976 and as Secretary since November 25, 2009. ... The following table sets forth summary information concerning compensation awarded to, paid to or earned by each of the following persons: (i) our Chairman of the Board, Chief Executive Officer and Secretary ... Elazar Rabbani, Ph.D. 2020 ... Total $1,487,801 |
2022-03-01 | Elazar Rabbani, Ph.D., is an Enzo Biochem founder and has served on the Company’s Board since its inception in 1976. Dr. Rabbani also served as the Company’s Chief Executive Officer from 1976 until November 2021, Chairman from 1976 until January 2022 and Secretary from November 2009 until January 2022. |
2022-12-21 | Elazar Rabbani, Ph.D., is an Enzo Biochem founder and served as the Company’s Chairman of the Board from its inception in 1976 to January 2022 and as Secretary from November 2009 to April 2022. Dr. Rabbani also served as the Company’s Chief Executive Officer from 1976 until November 2021. ... The following table sets forth the information concerning compensation earned during our fiscal year ended July 31, 2022 by all non-employee Directors: ... Elazar Rabbani $12,500 Fees Earned or Paid in Cash, — Restricted Stock Unit Awards, Total $12,500. |
Data sourced from SEC filings. Last updated: 2025-08-30